MiniMed appointed Sheila Denton as its general counsel and corporate secretary on September 28, placing an experienced pharmaceutical and biotechnology lawyer at the center of the company's legal work as it builds its future as an independent public company. The appointment took effect immediately.[1]
The role brings Denton into MiniMed's executive leadership at a consequential point for the diabetes technology business. Corporate Counsel reported that the appointment came six months after MiniMed separated from Medtronic, giving the company's new legal chief a broad assignment that reaches beyond day-to-day legal review.[2]
A career across regulated industries
Denton arrives with more than 25 years of experience in pharmaceutical and biotechnology companies. Most recently, she served as general counsel, corporate secretary and a member of the executive team at Incyte. Before that, she held a series of leadership positions at Boehringer Ingelheim in the United States and abroad, including U.S. general counsel and corporate head of strategic transactions.[1]
Her earlier work included private practice as a partner at Pullman & Comley. She earned her bachelor's degree from Sacred Heart University and her law degree from Western New England College School of Law.[1]
That combination of private-practice and in-house experience matters in a company where legal decisions may touch corporate governance, intellectual property, commercial transactions, litigation and regulation. MiniMed specifically cited those areas when describing Denton's background.[1]
MiniMed CEO Que Dallara said Denton brings "deep board experience, strong regulatory and transactional judgment, and a proven ability to build and lead high-performing global teams." The company also emphasized her experience advising organizations during periods of growth and change.[1]
Denton described the appointment in practical terms. "I'm excited to join MiniMed at such an important moment in the company's journey," she said in the announcement, connecting the legal leadership role to the company's work for people living with diabetes.[1]
Why the corporate secretary role matters
The title includes two responsibilities that often meet in the boardroom.[1] As general counsel, Denton will advise on the legal questions that accompany the company's operations and strategy. As corporate secretary, she will also have a central role in governance processes and communication with the board.
MiniMed's announcement did not present the position as a ceremonial promotion. It described a lawyer whose experience covers board service, regulated businesses and major transactions. Those are useful qualifications for a company adjusting to the responsibilities and scrutiny that come with operating independently in the public market.[1][2]
The appointment also adds another woman lawyer to the senior leadership ranks of a global health-technology company. That is worth noting without turning Denton's career into a symbol detached from the work itself. Her record is specific: senior legal leadership at Incyte, international responsibility at Boehringer Ingelheim, private practice, and more than two decades spent inside industries where science, regulation and business strategy regularly intersect.[1]
Experience that travels across disciplines
In-house legal leadership in health care and life sciences rarely stays within one lane. A transaction may involve regulatory questions. An intellectual-property issue may affect product strategy. A governance decision may require the legal team to translate risk for directors, executives and investors.
Denton's career has moved through those overlapping areas. MiniMed identified corporate governance, strategic transactions, intellectual property and litigation as parts of her professional background. The company said her experience leading global teams was another reason for the appointment.[1]
That breadth should give her a strong starting point. It also offers a useful example for lawyers building careers in regulated industries: technical legal knowledge remains essential, but senior leadership often depends on the ability to connect legal analysis with the decisions an organization must make.[1]
A new chapter for MiniMed's legal function
Denton succeeds Courtney Nelson Wills, who left MiniMed after a transition period to pursue another professional opportunity.[1] The change gives Denton responsibility for helping the company's board and executive team manage legal questions during its next phase.[1]
For women in law, appointments like this are most meaningful when the reporting stays close to the substance. Denton was not selected simply to occupy a prominent title. MiniMed chose a lawyer with a long record in pharmaceuticals, biotechnology, governance and transactions to serve as a senior adviser to the company and its board.[1]
Her first months will be measured by the work: how effectively the legal function supports sound governance, clear decisions and responsible growth. The appointment is a recognition of the experience she brings to that task.[1]
Influential Women in Law™ follows leadership appointments and professional achievements across the legal profession. Learn more about the honor or nominate a distinguished colleague.
Image credit
MiniMed 780G insulin pump and connected mobile device, photographed by MailariX and used under the Creative Commons Attribution-ShareAlike 4.0 license. No changes were made.[3]
Sources
[1] https://news.minimed.com/2026-09-28-MiniMed-appoints-Sheila-Denton-as-General-Counsel-Corporate-Secretary — MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary [2] https://www.law.com/corpcounsel/2026/09/28/medtronic-spinoff-minimed-taps-biopharma-veteran-as-gc — Medtronic Spinoff MiniMed Taps Biopharma Veteran as GC [3] https://commons.wikimedia.org/wiki/File:Medtronic_MiniMed_780G_insulinpump.jpg — Medtronic MiniMed 780G insulin pump image and license
